Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-01-13 @ 11:13 PM
Study NCT ID:
NCT02321592
Status:
COMPLETED
Last Update Posted:
2020-11-13
First Post:
2014-12-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Sponsor:
University of Cologne
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Uni-Koeln-1754
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None